Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1998. Start Trial.
Date Value
November 02, 2026 0.8683
October 30, 2026 0.87
October 29, 2026 0.8766
October 28, 2026 0.8777
October 27, 2026 0.8832
October 26, 2026 0.8722
October 23, 2026 0.8799
October 22, 2026 0.9025
October 21, 2026 0.8771
October 20, 2026 0.8915
October 19, 2026 0.8871
October 16, 2026 0.9168
October 15, 2026 0.9086
October 14, 2026 0.8793
October 13, 2026 0.8474
October 12, 2026 0.8518
October 09, 2026 0.8303
October 08, 2026 0.7994
October 07, 2026 0.8022
October 06, 2026 0.7718
October 05, 2026 0.7961
October 02, 2026 0.7862
October 01, 2026 0.7729
September 30, 2026 0.8137
September 29, 2026 0.827
Date Value
September 28, 2026 0.8325
September 25, 2026 0.8501
September 24, 2026 0.8093
September 23, 2026 0.763
September 22, 2026 0.7889
September 21, 2026 0.779
September 18, 2026 0.7476
September 17, 2026 0.7432
September 16, 2026 0.7465
September 15, 2026 0.7476
September 14, 2026 0.7525
September 11, 2026 0.7531
September 10, 2026 0.7492
September 09, 2026 0.7906
September 08, 2026 0.8038
September 04, 2026 0.8226
September 03, 2026 0.7867
September 02, 2026 0.7989
September 01, 2026 0.7955
August 31, 2026 0.8071
August 28, 2026 0.7983
August 27, 2026 0.7922
August 26, 2026 0.8137
August 25, 2026 0.7983
August 24, 2026 0.7867

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Eli Lilly & Co. 32.98
Merck & Co., Inc. 8.734
ANI Pharmaceuticals, Inc. 2.718
Corcept Therapeutics, Inc. 12.30
Veru, Inc. 1.298

Price to Book Value Related Metrics

PS Ratio 0.5281
PEG Ratio -0.0006
Price to Free Cash Flow 18.35
Price 15.75
Earnings Yield -79.43%
Market Cap 2.185B
PEGY Ratio -0.0006
Operating PE Ratio 8.226